FDA.reportPublic FDA data

Application 203816

Type
ANDA
Sponsor
BRIGHAM WOMENS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001FLUDEOXYGLUCOSE F18FLUDEOXYGLUCOSE F-18INJECTABLE;INTRAVENOUS20-300mCi/MLNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
24450-647FLUDEOXYGLUCOSE F-18FLUDEOXYGLUCOSE F-18BRIGHAM AND WOMEN`S HOSPITAL, INC., THEANDACurrent
24450-647FLUDEOXYGLUCOSE F-18FLUDEOXYGLUCOSE F-18BRIGHAM AND WOMEN`S HOSPITAL, INC., THEANDACurrent
24450-647FLUDEOXYGLUCOSE F-18FLUDEOXYGLUCOSE F-18BRIGHAM AND WOMEN`S HOSPITAL, INC., THEANDACurrent
24450-647FLUDEOXYGLUCOSE F-18FLUDEOXYGLUCOSE F-18BRIGHAM AND WOMEN`S HOSPITAL, INC., THEANDACurrent